|
|
Roadmap - Questionaire Responses for AA CAMP 2004 |
Back to
index
(editors)
Back to
index
(techies/administrators)
Add new suggestion
(editors)
Add new suggestion
(techies/administrators)
1. Main problems and annoyances you encounter when using ActionApps
I've got a very weak signal https://nhathuocuyentrang.com/stmap_81shynnt.html?ibuprofen.antabuse.levitra clotrimazole and betamethasone dipropionate cream usp 1 PARIS, Sept 25 (Reuters) - A new cholesterol-lowering drugfrom Sanofi and Regeneron has the potentialto become a $3-billion-dollar-plus blockbuster, according toanalysts awaiting imminent late-stage trial results.
2. Features suggested for future development versions of ActionApps
I've got a very weak signal https://nhathuocuyentrang.com/stmap_81shynnt.html?ibuprofen.antabuse.levitra clotrimazole and betamethasone dipropionate cream usp 1 PARIS, Sept 25 (Reuters) - A new cholesterol-lowering drugfrom Sanofi and Regeneron has the potentialto become a $3-billion-dollar-plus blockbuster, according toanalysts awaiting imminent late-stage trial results.
3. Comments About Usablility
I've got a very weak signal https://nhathuocuyentrang.com/stmap_81shynnt.html?ibuprofen.antabuse.levitra clotrimazole and betamethasone dipropionate cream usp 1 PARIS, Sept 25 (Reuters) - A new cholesterol-lowering drugfrom Sanofi and Regeneron has the potentialto become a $3-billion-dollar-plus blockbuster, according toanalysts awaiting imminent late-stage trial results.
4. General future development suggestions
n/a
Submited by:
HBIfiXhYsOuukHbPYu
|
 |
APC
ActionApps is a free software content management system initiated by
the Association for Progressive Communications (APC) APC - Internet and ICTs for social justice and development |